Author | Lightnews

pstudenic.bsky.social @pstudenic.bsky.social · Sep 29

Die @oegrr erweitert ihre Kommunikationsbandbreite💢

#Podcasts zu einer Vielfalt von #Rheuma Themen werden für alle Interessierte über den Herbst hinweg gelaunched!

Spannend für #Patientinnen sowie Gesundheitspersonal

1

Reposted

OEGRR @oegrr.bsky.social · Sep 14

Wir sind da! 🙂 🦴🩺
Folge uns um am Laufenden zu bleiben: Veranstaltungen, Deadlines🔬, Podcasts🎙️, Fortbildungen🩻und noch viel mehr!

Check up our Homepage to know more about us and our projects!
https://rheumatologie.at

2 2

pstudenic.bsky.social @pstudenic.bsky.social · Jul 2

Super happy and proud about the publication of the first authored paper of my #PhD student Nasim Nakhost Lotfi in RMD Open 😊👏🎈

How reliable can we utilise different #PROMs in #apps when assessed in different frequencies?
Have a look 👇

rmdopen.bmj.com/cgi/content/...

#Rheum
#ehealth
#arthritis

pstudenic.bsky.social @pstudenic.bsky.social · Jul 1

@mdr-ra-project.bsky.social GA has brought together our consortium in the heat of #Verona
These 2 days enabled clarity on setting the tracks to achieve our goals
Endotypes of #D2T #RA
Development of a clever #CDSS
😊 to co-lead the clinical deep phenotyping together with @drpetermandl.bsky.social

3

pstudenic.bsky.social @pstudenic.bsky.social · Jun 28

2 weeks ago #EULAR2025 closed. A congress full of education and innovation spread over 4 days.
Project Meetings (#Squeeze #Stratafit
EULAR Meetings (qoc #bigdata #atrisk)
2 lectures on #AIforIA & #PRPinvolvement
together with many conversations / exchanges and smiles filled my congress. ❤️ Thanks

1

Reposted

teresaoton.bsky.social @teresaoton.bsky.social · Jun 12

Christina Wettengl delivered an excellent oral presentation on the #ContextualAnalysis for the Care Model development in Switzerland for @squeezeproject.bsky.social #EULAR2025

1 6

pstudenic.bsky.social @pstudenic.bsky.social · Jun 14

#EULAR2025 also offered the possibilty to come together for scientific project meetings.
The @squeezeproject.bsky.social
Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas

3 9

pstudenic.bsky.social @pstudenic.bsky.social · Jun 14

One of the most crucial sessions for research in #rheumatology just started:

How to involve patients in your #research

💢Get your insights in #collaborativeresearch now
🤝
#EULAR2025
#PRP

1 9

Reposted

Simon Stones @simonrstones.bsky.social · Jun 13

Fantastic to see Sladjana, a STRATA-FIT patient research partner, presenting about the project and the evaluation of PRP involvement - partnership, communication, and support are critical #eular2025

2 5

Reposted

SQUEEZE project @squeezeproject.bsky.social · Jun 12

Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV

1 1 4

pstudenic.bsky.social @pstudenic.bsky.social · Jun 12

Very happy to see #TTV having the opportunity to be presented and discussed in the realm of #rheumatology
Great work of Daniel Mrak and interdisciplinary collaboration😊
POS0914
@squeezeproject.bsky.social
#EULAR2025

2 6

pstudenic.bsky.social @pstudenic.bsky.social · Jun 11

Very intense phenotyping of patients with RA in Remission double checked with #US comparing people tapering & stopping DMARD treatment with those continuing for the occurrence of #flare.
#spatialtranscriptomics #RNAseq #synovialbiopsy by Stefano Alivernini #EULAR2025

3

pstudenic.bsky.social @pstudenic.bsky.social · Jun 11

Join by at the poster presentation of Claudia Hana on trajectories of #MTX use in patients with RA this afternoon at m348
@squeezeproject.bsky.social
#EULAR2025

1 6

Reposted

The Lancet Rheumatology @thelancetrheum.bsky.social · Apr 17

ICYMI, the inspiration for our April cover—Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial bit.ly/3GpCl9X

Plus linked Comment bit.ly/4ivhVKo
#Medsky #Rheumsky

1 3

pstudenic.bsky.social @pstudenic.bsky.social · Apr 16

Thank you @gregorbond.bsky.social for enriching the frame of biomarkers in the field of #rheumatoidarthritis.
#TTV as biomarker of immunosuppression has for sure different facets.
I always enjoy the #interdisciplinary exchange

TTVguideTX @ttvguidetx.bsky.social · Apr 9

Our coordinator @gregorbond.bsky.social today, presenting results of TTV-guided monitoring at the @squeezeproject.bsky.social General Assembly meeting, supporting SQUEEZE leader of Functional Drug Monitoring, @pstudenic.bsky.social, with spreading the Torque Teno virus to #Rheumatology. #TTVguide

4

pstudenic.bsky.social @pstudenic.bsky.social · Apr 5

The last two days were dedicated to intense discussions, phrasing Update recommendations for large vessel #vasculitis
- #LVV -
Combining expertise from 15 countries
Thanks to the leads C. Mukhtyar, B. Hellmich & E. Nikiphorou & the marvelous fellows @drminidey.bsky.social D. Misra A. Bartoletti

2 3

pstudenic.bsky.social @pstudenic.bsky.social · Mar 22

#Digitalrheumatology days update
#RCT including people with inflammatory #arthritis and #SLE subjecting to either #CBT or leaflet information about #depression and anxiety
CBT was integrated into a 90 days program delivered via a smartphone app.
Promising results presented by @johannesknitza 👇

2 4

pstudenic.bsky.social @pstudenic.bsky.social · Mar 22

These days the #Digital #Rheumatology days are on again in #Berlin. #7th Edition
An interdisciplinary audience from 19 countries come together. 🌐
I had the pleasure to provide an update of developments over the past year in #digitalhealth #ehealth
New insights and productive exchange 💢

2 6

Reposted

European Commission @ec.europa.eu · Mar 13

Say hello to Europe's six new new AI Factories:

🇦🇹 AI:AT
🇧🇬 BRAIN++
🇫🇷 AI2F
🇩🇪 JAIF
🇵🇱 PIAST
🇸🇮 SLAIF

These factories will help startup, small and medium companies develop AI models using top supercomputing power, data, and talent ↓

europa.eu/!F6KGPG

A map of Europe highlighting the locations of six new AI factories established by the European Union. The factories are marked with icons and are distributed as follows: Selected in December 2024 (blue markers): MIMER AI Factory at the University of Linköping, Sweden, ITALIA AI Factory at CINECA, Italy; BSC AI Factory at the Barcelona Supercomputing Centre, Spain; HammerHAI at the University of Stuttgart, Germany; Meluxina-AI at the LuxPriovide, Luxembourg; Pharos at GRNET, Greece. Selected in March 2025 (purple markers): AI2F in Bruyères-le-Châtel, France; JAIF in Jülich, Germany, PIAST AIF in Poznań, Poland; AIAAT in Vienna, Austria, SLAIF in Maribor, Slovenia; BRAIN++ in Sofia, Bulgaria. The map uses shades of purple to indicate the countries where the factories are located and includes EU branding at the top.

12 61 290

Reposted

ACR Journals @acr-journals.bsky.social · Mar 11

Cross-sectional study in the VA rheumatoid arthritis registry identified 8 peripheral blood biomarkers that could improve RA-interstitial lung disease risk stratification beyond clinical risk factors

In A&R
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#Medsky #Pulmsky

Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Graphical abstract created with BioRender

2 2

pstudenic.bsky.social @pstudenic.bsky.social · Mar 8

International women's day
8th of March
developments in steps
Studying #medicine for women in Vienna was possible only since the start of the 20th century
Dr. Anna Fischer-Dückelmann underwent med school in switzerland before publishing the book 👇 a novelty back then and reprinted over decades

1

Reposted

ACR Journals @acr-journals.bsky.social · Feb 21

Bayesian meta-analysis of RCTs compared efficacy and safety of JAK inhibitors vs bDMARDs for nonsystemic forms of juvenile idiopathic arthritis. Results showed no significant difference in efficacy and safety outcomes among the treatment options

In ACROR
doi.org/10.1002/acr2...
#Medsky

Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease-Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta-Analysis of Randomized Controlled Trials. Graphical abstract created with BioRender

2 2

pstudenic.bsky.social @pstudenic.bsky.social · Feb 17

FIRST #EULAR Quality of Care webinar
"Diagnosis and Treatment of Giant Cell Arteritis"!

Wednesday, 19 February 2025, 17:00 -18:00 CET

This one touches on the products of EULAR aiming to aid #rheumatologists in different aspects around #GCA!

Register here👉 lnkd.in/dct7mYAC

1

Reposted

MDR-RA Project @mdr-ra-project.bsky.social · Jan 27

Exciting news!🎉The official #HorizonEurope #MDRRAProject press release has been published by our coordinator, Humanitas University!🌍Learn more about how we’re tackling multi-drug resistant #RA through groundbreaking #research and #collaboration. Stay tuned for updates! #MDRRA #HorizonEU #EUProject

Humanitas University coordinates a European project on multi-drug resistant rheumatoid arthritis - Hunimed

The MDR-RA (Multi-Drug Resistance in Rheumatoid Arthritis) project has officially started: it’s an international research initiative, with a total budget

www.hunimed.eu

1 5